Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2515.89 (Glytoucan)

Id:605bfc34-8fb4-58c8-a84a-6f9d7ee5d3de

Glytoucan:G42283OX

Results found

Linked to

	Label	Description
	2515.89 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2515.89 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000071 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G42283OX-GLYCOSEQ00201980 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2515.89 has canonical residue n-glycan b-d-glcpnac 5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G72317JJ-GLYCOSEQ00055395 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G69362MR-GLYCOSEQ00172639 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2515.89 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000110 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G27899VX-GLYCOSEQ00186777 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2515.89 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000008 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G69362MR-GLYCOSEQ00172641 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000071 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G42283OX-GLYCOSEQ00201980 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 has canonical residue n-glycan b-d-glcpnac 5

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G72317JJ-GLYCOSEQ00055395 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G69362MR-GLYCOSEQ00172639 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000110 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G27899VX-GLYCOSEQ00186777 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000008 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2515.89 has glycosequence GLYGEN.GLYCOSEQUENCE:G69362MR-GLYCOSEQ00172641 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.